Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.

Khariwala SS, Carmella SG, Stepanov I, Bandyopadhyay D, Nelson HH, Yueh B, Hatsukami DK, Hecht SS.

Laryngoscope. 2015 Apr 15. doi: 10.1002/lary.25290. [Epub ahead of print]

PMID:
25877866
2.

CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis-A Meta-Analysis.

Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach AK, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Heinrich J, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ.

J Natl Cancer Inst. 2015 Apr 14;107(5). pii: djv100. doi: 10.1093/jnci/djv100. Print 2015 May. Review.

PMID:
25873736
3.

Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.

Zhu AZ, Cox LS, Ahluwalia JS, Renner CC, Hatsukami DK, Benowitz NL, Tyndale RF.

Pharmacogenet Genomics. 2015 May;25(5):263-9. doi: 10.1097/FPC.0000000000000135.

PMID:
25794161
4.

The effect of tobacco additives on smoking initiation and maintenance.

Ferreira CG, Silveira D, Hatsukami DK, Paumgartten FJ, Fong GT, Glória MB, Toledo MC, Talhout R.

Cad Saude Publica. 2015 Feb;31(2):223-5. No abstract available.

5.

Circulating leptin and pain perception among tobacco-dependent individuals.

al'Absi M, Lemieux A, Nakajima M, Hatsukami DK, Allen S.

Biol Psychol. 2015 Apr;107:10-5. doi: 10.1016/j.biopsycho.2015.02.008. Epub 2015 Feb 23.

PMID:
25720946
6.

Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.

Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW.

Clin Cancer Res. 2015 Feb 1;21(3):514-25. doi: 10.1158/1078-0432.CCR-14-2544. Epub 2015 Jan 8.

PMID:
25573384
7.

Electronic nicotine delivery systems: a policy statement from the American Association forCancer Research and theAmerican Society of Clinical Oncology.

Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW.

J Clin Oncol. 2015 Mar 10;33(8):952-63. doi: 10.1200/JCO.2014.59.4465. Epub 2015 Jan 8.

PMID:
25572671
8.

Evidence supporting product standards for carcinogens in smokeless tobacco products.

Hatsukami DK, Stepanov I, Severson H, Jensen JA, Lindgren BR, Horn K, Khariwala SS, Martin J, Carmella SG, Murphy SE, Hecht SS.

Cancer Prev Res (Phila). 2015 Jan;8(1):20-6. doi: 10.1158/1940-6207.CAPR-14-0250. Epub 2014 Dec 18.

PMID:
25524878
9.

Compensatory smoking from gradual and immediate reduction in cigarette nicotine content.

Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):472-6. doi: 10.1158/1055-9965.EPI-14-0739. Epub 2014 Dec 16.

PMID:
25515551
10.

Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes.

Benowitz NL, Nardone N, Hatsukami DK, Donny EC.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):331-5. doi: 10.1158/1055-9965.EPI-14-1040. Epub 2014 Nov 21.

PMID:
25416718
11.

NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214. Epub 2014 Oct 21.

PMID:
25335949
12.

Evaluation of Toxicant and Carcinogen Metabolites in the Urine of e-Cigarette Users Versus Cigarette Smokers.

Hecht SS, Carmella SG, Kotandeniya D, Pillsbury ME, Chen M, Ransom BW, Vogel RI, Thompson E, Murphy SE, Hatsukami DK.

Nicotine Tob Res. 2014 Oct 21. pii: ntu218. [Epub ahead of print]

PMID:
25335945
13.

Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation.

Dermody SS, Donny EC, Hertsgaard LA, Hatsukami DK.

Tob Control. 2014 Sep 5. pii: tobaccocontrol-2014-051797. doi: 10.1136/tobaccocontrol-2014-051797. [Epub ahead of print]

PMID:
25192771
14.

Liquid chromatography-electrospray ionization-tandem mass spectrometry quantitation of urinary [pyridine-D4]4-hydroxy-4-(3-pyridyl)butanoic acid, a biomarker of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation in smokers.

Jing M, Wang Y, Upadhyaya P, Jain V, Yuan JM, Hatsukami DK, Hecht SS, Stepanov I.

Chem Res Toxicol. 2014 Sep 15;27(9):1547-55. doi: 10.1021/tx5001915. Epub 2014 Aug 25.

PMID:
25098652
15.

Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach.

Smith TT, Sved AF, Hatsukami DK, Donny EC.

Prev Med. 2014 Nov;68:23-8. doi: 10.1016/j.ypmed.2014.07.005. Epub 2014 Jul 13.

PMID:
25025523
16.

Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.

Donny EC, Hatsukami DK, Benowitz NL, Sved AF, Tidey JW, Cassidy RN.

Prev Med. 2014 Nov;68:17-22. doi: 10.1016/j.ypmed.2014.06.020. Epub 2014 Jun 23.

PMID:
24967958
17.

Sex differences in response to reduced nicotine content cigarettes.

Vogel RI, Hertsgaard LA, Dermody SS, Luo X, Moua L, Allen S, al'Absi M, Hatsukami DK.

Addict Behav. 2014 Jul;39(7):1197-204. doi: 10.1016/j.addbeh.2014.03.021. Epub 2014 Mar 30.

PMID:
24746485
18.

Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.

Stepanov I, Biener L, Yershova K, Nyman AL, Bliss R, Parascandola M, Hatsukami DK.

Nicotine Tob Res. 2014 Aug;16(8):1070-8. doi: 10.1093/ntr/ntu026. Epub 2014 Mar 6.

PMID:
24604020
19.

Snus use and rejection in the USA.

Biener L, Roman AM, Mc Inerney SA, Bolcic-Jankovic D, Hatsukami DK, Loukas A, O'Connor RJ, Romito L.

Tob Control. 2014 Feb 25. doi: 10.1136/tobaccocontrol-2013-051342. [Epub ahead of print]

PMID:
24570100
20.

Multiple distinct CHRNB3-CHRNA6 variants are genetic risk factors for nicotine dependence in African Americans and European Americans.

Culverhouse RC, Johnson EO, Breslau N, Hatsukami DK, Sadler B, Brooks AI, Hesselbrock VM, Schuckit MA, Tischfield JA, Goate AM, Saccone NL, Bierut LJ.

Addiction. 2014 May;109(5):814-22. doi: 10.1111/add.12478. Epub 2014 Feb 18.

PMID:
24401102
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk